Validation of the patient health questionnaire (PHQ)-9 and PHQ-2 in patients with COPD in China
Open Access
- 1 July 2025
- journal article
- research article
- Published by Springer Nature in BMC Psychiatry
- Vol. 25 (1) , 1-9
Abstract
Patient Health Questionnaire (PHQ-9) and PHQ-2 are commonly used screening tools for depression but have not been validated in Chronic obstructive pulmonary disease (COPD) patients. We aimed to validate PHQ-9 and PHQ-2 among COPD patients in China. Stable COPD patients were assessed using a PHQ-9 questionnaire and then assessed by a senior psychiatrist to confirm the diagnosis of major depressive disorder (MDD) according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Receiver operating characteristic curve analysis was performed to validate the PHQ-9/PHQ-2. Out of 265 COPD patients, 11.7% were diagnosed with MDD. The Cronbach’s α-coefficient for PHQ-9 was 0.751. Both PHQ-9 and PHQ-2 showed good correlations with COPD symptoms and quality of life. The AUC values of PHQ-9 and PHQ-2 were 0.848 and 0.736, respectively, for identifying MDD. Based on the highest Youden index, the optimal cut-off scores were PHQ-9 ≥ 7 and PHQ-2 ≥ 2, with a sensitivity of 74.2% and 58.1% and specificity of 89.7% and 89.3%, respectively. PHQ-9 score ≥ 7 and PHQ-2 score ≥ 2 should be used as the optimal cut-offs for COPD patients in China. PHQ-9 is a valid tool for detecting MDD in COPD patients, while PHQ-2 (score < 2) is more useful for quickly excluding MDD.Keywords
Funding Information
- the Beijing Hospitals Authority Innovation Studio of Young Staff Funding Support (202108)
- the Financial Budgeting Project of Beijing Institute of Respiratory Medicine (Ysbz2024001)
- the Project of “Deng Feng” Talent Training, the Beijing Municipal Administration of Hospitals (DFL20190301)
- the National Key R&D Program of China, the Ministry of Science and Technology of China (2016YFC0901102)
- AstraZeneca China (ESR-16-12485)
This publication has 34 references indexed in Scilit:
- Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease in China: a cross-sectional case control studyBMC Pulmonary Medicine, 2012
- Prevalence of depressive symptoms in patients with chronic obstructive pulmonary disease: a systematic review, meta-analysis and meta-regressionGeneral Hospital Psychiatry, 2011
- Determinants of Depression in the ECLIPSE Chronic Obstructive Pulmonary Disease CohortAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Validation of PHQ-2 and PHQ-9 to Screen for Major Depression in the Primary Care PopulationThe Annals of Family Medicine, 2010
- COPD and the Risk of DepressionChest, 2010
- Reliability and validity of the PHQ‐9 for screening late‐life depression in Chinese primary careInternational Journal of Geriatric Psychiatry, 2009
- Summed score of the Patient Health Questionnaire-9 was a reliable and valid method for depression screening in chronically ill elderly patientsJournal of Clinical Epidemiology, 2008
- Standardisation of spirometryEuropean Respiratory Journal, 2005
- The Patient Health Questionnaire-2Medical Care, 2003
- The PHQ-9Journal of General Internal Medicine, 2001